Answers are grounded in this paper and cite their sources.
Breast cancer precision therapy faces drug delivery and response prediction challenges. Ultrasound micro/nanobubble platforms integrate theranostic functions but lack consistent evidence. A scoping review following the Arksey and O’Malley framework and Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines systematically searched PubMed, Web of Science, and Embase (January 2010-March 2026), screened 2,086 records and analyzed 38 studies on ultrasound-triggered microbubble/nanobubble platforms. It mapped evidence in imaging, local delivery and immunotherapy, and proposed their optimal role as immunotherapy delivery sensitization modules.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: